[ Price : $8.95]
HHS Office of Inspector General abolishes a controversial memorandum of understanding that allowed FDAs Office of Internal Affairs...[ Price : $8.95]
FDA tentatively approves a Caraco Pharmaceutical Laboratories ANDA for a generic copy of GlaxoSmithKlines Lamictal (lamotrigine) t...[ Price : $8.95]
Health Canada restricts most monotherapy and combination uses of GlaxoSmithKlines Avandia.[ Price : $8.95]
Cephalon submits an sNDA to FDA for a Fentora indication for managing breakthrough pain in opioid tolerant patients.[ Price : $8.95]
FDA approves GeoPharmas generic form of Pfizers canine drug Rimadyl in three strengths.[ Price : $8.95]
AtheroGenics drops the 300 mg dose from its AGI-1067 ANDES clinical trial due to adverse effects on the liver seen in an earlier t...